The chemokine receptor CXCR4 is a co-receptor of human immunodeficiency virus (HIV) (Feng et al., 1996) . Physiologically, CXCR4 interacts with stromal cellderived factor 1 (SDF-1) and allows CXCR4-expressing cells to home to the loci where SDF-1 is highly expressed (Kucia et al., 2004) . For example, the roles of SDF-1 and CXCR4 are essential in human stem cell homing and repopulation of the host with differentiated hematopoietic cells (Kucia et al., 2005; Lapidot and Kollet, 2002) . SDF-1 is also produced by thymus epithelial cells and plays an important role in migration of immature progenitors in the thymus (Plotkin et al., 2003) . In contrast to another HIV-1 co-receptor CCR5, which has a widely-distributed deletion mutant called 32 in Caucasian populations (Stephens et al., 1998) , the physiological roles of CXCR4 are indispensable.
Therefore, it will be important to better understand the impact of CXCR4-tropic HIV-1 infection upon hematopoiesis-related events including T cell development in the thymus. Bone marrow abnormalities such as dysplasia and abnormal hematopoietic cell development are frequently observed in HIV infected individuals (Tripathi et al., 2005) .
Thymus dysfunction occurs during HIV disease and its rapid progression in infants is associated with prenatal HIV infection (Ye, Kirschner, and Kourtis, 2004) .
HIV-1 has recently been shown to infect human CD34
+ hematopoietic progenitor cells (Carter et al., 2011; Carter et al., 2010) . On the other hand, hematopoietic stem/progenitor cells (HSPC) limit HIV infection in different ways. One is the extremely low expression levels of the receptors on these cells (Carter et al., 2011) .
Besides, some reports indicate mechanisms restricting HIV-1 prior to integration (Griffin and Goff, 2015) . These may prevent researchers from detailed in vitro analysis of CD34 + cells in the presence of HIV-1. To overcome the limitations, the authors not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/142075 doi: bioRxiv preprint first posted online May. 25, 2017;  propose a method to mediate HIV-1 entry to CD34 + cells by using RetroNectin (RN), a recombinant fibronectin fragment that enhances retroviral-mediated gene transduction by aiding the co-localization of target cells and virions.
RetroNectin has been tested with vesicular stomatitis virus glycoprotein (VSV-G), murine ecotropic/amphotroic/xenotropic retrovirus envelopes (Lee, Sadelain, and Brentjens, 2009; Relander et al., 2001; Sakuma et al., 2010) , and gibbon ape leukemia virus (GaLV) envelopes (Chono et al., 2001 RetroNectin (Takara Bio Inc., Tokyo, Japan) at a concentration of 10 µg/mL following the manufacturer's protocol. The media for infection and culture was MEM-α supplemented with 10 % heat inactivated fetal bovine serum (FBS), 5 ng/mL of recombinant human interleukin 7 (IL-7), and 5 ng/mL of FMS-like tyrosine kinase 3 ligand (Flt3L). After adding 200 ng (p24) of HIV-1 NL4-3 (Adachi et al., 1986) , the plate was kept at 34 °C, centrifuged at 1,200 g for 30 minutes, and cultured overnight at 37 °C.
Cells were then transferred to a coculture with a mouse stromal cell line OP9-DL1 ( Fig   1A) (Zuniga-Pflucker, 2009).
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The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/142075 doi: bioRxiv preprint first posted online May. 25, 2017;  Samples were analyzed at week 1 post infection and coculture. Cells were stained with anti-human CD34 APC (BD Biosciences, Tokyo, Japan) and anti-HIV-1 p24 PE Fig 1C) . In all the RN-treated samples tested (n=17), the intracellular p24 + frequencies were higher than 0.20 (Table 1) , manifesting the reliability of the method for infection of relatively virus-resistant CD34 + cells. With all the samples tested, RNassisted HIV-1 infection of CD34 + cells lasted at least for 5 weeks ( Fig 1D) . It was also checked that merely treating CD34 + cells with RN without HIV-1 infection didn't cause any changes to the cells in terms of the whole cell counts and CD34/CXCR4 expression levels, when compared to RN-untreated cells (data not shown).
To confirm the enhancing effect of RN on HIV-1 entry, the whole cord blood mononuclear cells were infected with HIV-1 NL4-3 in an RN-coated or -uncoated well.
After the centrifugation as above, followed by a culture for a week in RPMI1640 media supplemented with 10 % FBS and 20 IU/mL IL-2, cells were stained with anti-human CD4 PerCP-Cy5.5 (BioLegend, Tokyo, Japan) and anti-HIV-1 p24 PE, and analyzed on flow cytometry. As shown in Fig 1E, RN also supported HIV-1 infection of blood not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission. . 25, 2017; the samples tested with RN-coated plate showed stable HIV-1 infection for 5 weeks.
The method may be applicable to any combination of virus-resistant suspension cells and a virus like retroviruses, bringing long-term in vitro analyses of infected cells, including rare or precious cell samples, close to researchers' hands.
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